PortfoliosLab logo

Arcturus Therapeutics Holdings Inc. (ARCT)

Equity · Currency in USD · Last updated Jan 31, 2023

Company Info

ISINUS03969T1097
CUSIP03969T109
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$20.59
Year Range$12.26 - $31.17
EMA (50)$18.14
EMA (200)$19.39
Average Volume$455.39K
Market Capitalization$546.78M

ARCTShare Price Chart


Loading data...

ARCTPerformance

The chart shows the growth of $10,000 invested in Arcturus Therapeutics Holdings Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,835 for a total return of roughly -61.65%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2023
16.74%
-1.80%
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)

ARCTCompare to other instruments

Search for stocks, ETFs, and funds to compare with ARCT

ARCTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M19.52%4.64%
YTD19.52%4.64%
6M15.50%-2.72%
1Y-9.10%-9.34%
5Y20.47%7.33%
10Y-9.43%9.59%

ARCTMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202211.50%-20.00%5.56%19.43%4.18%-8.03%

ARCTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arcturus Therapeutics Holdings Inc. Sharpe ratio is -0.05. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00SeptemberOctoberNovemberDecember2023
-0.05
-0.29
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)

ARCTDividend History


Arcturus Therapeutics Holdings Inc. doesn't pay dividends

ARCTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%SeptemberOctoberNovemberDecember2023
-88.65%
-16.24%
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)

ARCTWorst Drawdowns

The table below shows the maximum drawdowns of the Arcturus Therapeutics Holdings Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arcturus Therapeutics Holdings Inc. is 97.70%, recorded on Dec 28, 2018. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.7%Oct 8, 20131316Dec 28, 2018
-14.65%Aug 6, 201321Sep 4, 20134Sep 10, 201325
-12.05%May 23, 201322Jun 24, 20139Jul 8, 201331
-7.48%Jul 15, 20134Jul 18, 201310Aug 1, 201314
-7.2%Sep 16, 20137Sep 24, 20132Sep 26, 20139
-3.58%Sep 30, 20131Sep 30, 20132Oct 2, 20133

ARCTVolatility Chart

Current Arcturus Therapeutics Holdings Inc. volatility is 36.32%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%SeptemberOctoberNovemberDecember2023
36.32%
18.51%
ARCT (Arcturus Therapeutics Holdings Inc.)
Benchmark (^GSPC)